- Home
- NWL vs IMTX Comparison
NWL vs IMTX Comparison
Compare NWL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWL | IMTX |
|---|---|---|
| Founded | 1903 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Plastic Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | NWL | IMTX |
|---|---|---|
| Price | $3.84 | $10.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $4.97 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 6.9M | 577.8K |
| Earning Date | 05-01-2026 | 05-13-2026 |
| Dividend Yield | ★ 7.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,742,200,000.00 | N/A |
| Revenue This Year | $1.19 | N/A |
| Revenue Next Year | $1.58 | $25.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.14 | N/A |
| 52 Week Low | $3.07 | $5.05 |
| 52 Week High | $6.64 | $12.41 |
Technical Indicators
Market Signals| Indicator | NWL | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 42.00 |
| Support Level | $3.58 | $9.24 |
| Resistance Level | $3.89 | $10.80 |
| Average True Range (ATR) | 0.17 | 0.62 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 73.38 | 28.24 |
Price Performance
Historical ComparisonAbout NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.